サマリー

世界のアジソン病治療薬市場 2023-2027
Technavioはアジソン病治療薬市場を監視しており、2023年から2027年にかけて442百万ドルの成長が見込まれ、予測期間中にCAGR 6.93%で加速しています。当レポートでは、アジソン病治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、特効薬の指定、医薬品の再製剤化、有利な償還シナリオによって牽引されています。
Technavioのアジソン病治療薬市場は、以下のように区分されています。
治療法別
- 経口薬
- 非経口薬
エンドユーザー別
- 病院
- 診療所
- 診断機関
地域別構成比
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間におけるアジソン病治療薬市場の成長を促進する主要な理由の一つとして、再生療法の開発研究の拡大を挙げています。また、臨床ガイドラインの利用可能性と再定義された病態生理は、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な図を提示します。アジソン病治療薬市場に関する当レポートは、以下の分野を対象としています。
- アジソン病治療薬市場のサイジング
- アジソン病治療薬市場の予測
- アジソン病治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Actiza Pharmaceutical Pvt. Ltd., Akorn Operating Co.LLC、Amneal Pharmaceuticals Inc.、Bristol Myers Squibb Co.、Neurocrine Biosciences Inc.、Hikma Pharmaceuticals Plc、Merck and Co.Inc.、ノバルティスAG、ファイザー株式会社、武田薬品工業株式会社、日本ケンタッキー・フライド・チキン株式会社、日本ケンタッキー・フライド・チキン株式会社グラクソ・スミスクライン社、アボット・ラボラトリーズ社、アムジェン社、イーライリリー社、バイオジェン社、ベーリンガー・インゲルハイム社、バイオテクネ社、ルパン社、BTL Biotechno Labs Pvt. Ltd.、バイエル社。また、アジソン病治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/addisons-disease-therapeutics-market-industry-analysis をご覧ください。
Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数のソースからのデータの調査、合成、総括を行い、市場の詳細な姿を提示します。業界の主要な影響力を持つ人物を特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global addisons disease therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global addisons disease therapeutics market 2017 - 2021 ($ million)
o 4.2 Therapy Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Therapy
o 6.1 Market segments
o Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
o 6.2 Comparison by Therapy
o Exhibit 32: Chart on Comparison by Therapy
o Exhibit 33: Data Table on Comparison by Therapy
o 6.3 Oral drugs - Market size and forecast 2022-2027
o Exhibit 34: Chart on Oral drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oral drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oral drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oral drugs - Year-over-year growth 2022-2027 (%)
o 6.4 Parenteral drugs - Market size and forecast 2022-2027
o Exhibit 38: Chart on Parenteral drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Parenteral drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Parenteral drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Parenteral drugs - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Therapy
o Exhibit 42: Market opportunity by Therapy ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 45: Chart on Comparison by End-user
o Exhibit 46: Data Table on Comparison by End-user
o 7.3 Hospitals and clinics - Market size and forecast 2022-2027
o Exhibit 47: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
o 7.4 Diagnostic laboratories - Market size and forecast 2022-2027
o Exhibit 51: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 55: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 97: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 104: Abbott Laboratories - Overview
o Exhibit 105: Abbott Laboratories - Business segments
o Exhibit 106: Abbott Laboratories - Key news
o Exhibit 107: Abbott Laboratories - Key offerings
o Exhibit 108: Abbott Laboratories - Segment focus
o 12.4 Actiza Pharmaceutical Pvt. Ltd.
o Exhibit 109: Actiza Pharmaceutical Pvt. Ltd. - Overview
o Exhibit 110: Actiza Pharmaceutical Pvt. Ltd. - Product / Service
o Exhibit 111: Actiza Pharmaceutical Pvt. Ltd. - Key offerings
o 12.5 Akorn Operating Co. LLC
o Exhibit 112: Akorn Operating Co. LLC - Overview
o Exhibit 113: Akorn Operating Co. LLC - Product / Service
o Exhibit 114: Akorn Operating Co. LLC - Key offerings
o 12.6 Amgen Inc.
o Exhibit 115: Amgen Inc. - Overview
o Exhibit 116: Amgen Inc. - Product / Service
o Exhibit 117: Amgen Inc. - Key offerings
o 12.7 Amneal Pharmaceuticals Inc.
o Exhibit 118: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 120: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus
o 12.8 Bayer AG
o Exhibit 123: Bayer AG - Overview
o Exhibit 124: Bayer AG - Business segments
o Exhibit 125: Bayer AG - Key offerings
o Exhibit 126: Bayer AG - Segment focus
o 12.9 Bristol Myers Squibb Co.
o Exhibit 127: Bristol Myers Squibb Co. - Overview
o Exhibit 128: Bristol Myers Squibb Co. - Product / Service
o Exhibit 129: Bristol Myers Squibb Co. - Key offerings
o 12.10 Eli Lilly and Co.
o Exhibit 130: Eli Lilly and Co. - Overview
o Exhibit 131: Eli Lilly and Co. - Product / Service
o Exhibit 132: Eli Lilly and Co. - Key offerings
o 12.11 GlaxoSmithKline Plc
o Exhibit 133: GlaxoSmithKline Plc - Overview
o Exhibit 134: GlaxoSmithKline Plc - Business segments
o Exhibit 135: GlaxoSmithKline Plc - Key offerings
o Exhibit 136: GlaxoSmithKline Plc - Segment focus
o 12.12 Hikma Pharmaceuticals Plc
o Exhibit 137: Hikma Pharmaceuticals Plc - Overview
o Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
o 12.13 Merck and Co. Inc.
o Exhibit 141: Merck and Co. Inc. - Overview
o Exhibit 142: Merck and Co. Inc. - Business segments
o Exhibit 143: Merck and Co. Inc. - Key news
o Exhibit 144: Merck and Co. Inc. - Key offerings
o Exhibit 145: Merck and Co. Inc. - Segment focus
o 12.14 Neurocrine Biosciences Inc.
o Exhibit 146: Neurocrine Biosciences Inc. - Overview
o Exhibit 147: Neurocrine Biosciences Inc. - Product / Service
o Exhibit 148: Neurocrine Biosciences Inc. - Key offerings
o 12.15 Novartis AG
o Exhibit 149: Novartis AG - Overview
o Exhibit 150: Novartis AG - Business segments
o Exhibit 151: Novartis AG - Key offerings
o Exhibit 152: Novartis AG - Segment focus
o 12.16 Pfizer Inc.
o Exhibit 153: Pfizer Inc. - Overview
o Exhibit 154: Pfizer Inc. - Product / Service
o Exhibit 155: Pfizer Inc. - Key news
o Exhibit 156: Pfizer Inc. - Key offerings
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 159: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 161: Inclusions checklist
o Exhibit 162: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 163: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 164: Research methodology
o Exhibit 165: Validation techniques employed for market sizing
o Exhibit 166: Information sources
o 13.5 List of abbreviations
o Exhibit 167: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global addisons disease therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on Oral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral drugs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral drugs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Parenteral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Parenteral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Parenteral drugs - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Parenteral drugs - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Therapy ($ million)
Exhibits43: Chart on End-user - Market share 2022-2027 (%)
Exhibits44: Data Table on End-user - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by End-user
Exhibits46: Data Table on Comparison by End-user
Exhibits47: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by End-user ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: Abbott Laboratories - Overview
Exhibits105: Abbott Laboratories - Business segments
Exhibits106: Abbott Laboratories - Key news
Exhibits107: Abbott Laboratories - Key offerings
Exhibits108: Abbott Laboratories - Segment focus
Exhibits109: Actiza Pharmaceutical Pvt. Ltd. - Overview
Exhibits110: Actiza Pharmaceutical Pvt. Ltd. - Product / Service
Exhibits111: Actiza Pharmaceutical Pvt. Ltd. - Key offerings
Exhibits112: Akorn Operating Co. LLC - Overview
Exhibits113: Akorn Operating Co. LLC - Product / Service
Exhibits114: Akorn Operating Co. LLC - Key offerings
Exhibits115: Amgen Inc. - Overview
Exhibits116: Amgen Inc. - Product / Service
Exhibits117: Amgen Inc. - Key offerings
Exhibits118: Amneal Pharmaceuticals Inc. - Overview
Exhibits119: Amneal Pharmaceuticals Inc. - Business segments
Exhibits120: Amneal Pharmaceuticals Inc. - Key news
Exhibits121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits122: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits123: Bayer AG - Overview
Exhibits124: Bayer AG - Business segments
Exhibits125: Bayer AG - Key offerings
Exhibits126: Bayer AG - Segment focus
Exhibits127: Bristol Myers Squibb Co. - Overview
Exhibits128: Bristol Myers Squibb Co. - Product / Service
Exhibits129: Bristol Myers Squibb Co. - Key offerings
Exhibits130: Eli Lilly and Co. - Overview
Exhibits131: Eli Lilly and Co. - Product / Service
Exhibits132: Eli Lilly and Co. - Key offerings
Exhibits133: GlaxoSmithKline Plc - Overview
Exhibits134: GlaxoSmithKline Plc - Business segments
Exhibits135: GlaxoSmithKline Plc - Key offerings
Exhibits136: GlaxoSmithKline Plc - Segment focus
Exhibits137: Hikma Pharmaceuticals Plc - Overview
Exhibits138: Hikma Pharmaceuticals Plc - Business segments
Exhibits139: Hikma Pharmaceuticals Plc - Key offerings
Exhibits140: Hikma Pharmaceuticals Plc - Segment focus
Exhibits141: Merck and Co. Inc. - Overview
Exhibits142: Merck and Co. Inc. - Business segments
Exhibits143: Merck and Co. Inc. - Key news
Exhibits144: Merck and Co. Inc. - Key offerings
Exhibits145: Merck and Co. Inc. - Segment focus
Exhibits146: Neurocrine Biosciences Inc. - Overview
Exhibits147: Neurocrine Biosciences Inc. - Product / Service
Exhibits148: Neurocrine Biosciences Inc. - Key offerings
Exhibits149: Novartis AG - Overview
Exhibits150: Novartis AG - Business segments
Exhibits151: Novartis AG - Key offerings
Exhibits152: Novartis AG - Segment focus
Exhibits153: Pfizer Inc. - Overview
Exhibits154: Pfizer Inc. - Product / Service
Exhibits155: Pfizer Inc. - Key news
Exhibits156: Pfizer Inc. - Key offerings
Exhibits157: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits158: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits159: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits160: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits161: Inclusions checklist
Exhibits162: Exclusions checklist
Exhibits163: Currency conversion rates for US$
Exhibits164: Research methodology
Exhibits165: Validation techniques employed for market sizing
Exhibits166: Information sources
Exhibits167: List of abbreviations